Moneycontrol
Get App
SENSEX NIFTY
you are here:

Astec Lifesciences Ltd.

BSE: 533138 | NSE: ASTEC |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE563J01010 | SECTOR: Pharmaceuticals

BSE Live

Apr 08, 12:05
450.00 11.65 (2.66%)
Volume
AVERAGE VOLUME
5-Day
849
10-Day
685
30-Day
1,147
100
  • Prev. Close

    438.35

  • Open Price

    450.00

  • Bid Price (Qty.)

    440.95 (32)

  • Offer Price (Qty.)

    448.35 (94)

NSE Live

Apr 08, 12:05
447.50 3.60 (0.81%)
Volume
AVERAGE VOLUME
5-Day
32,748
10-Day
40,921
30-Day
24,977
1,515
  • Prev. Close

    443.90

  • Open Price

    450.65

  • Bid Price (Qty.)

    442.35 (1)

  • Offer Price (Qty.)

    446.95 (2)

ANNOUNCEMENTS ON Astec Life

  • Mar 31, 2020 19:50 Source: BSE

    Astec Lifesciences - Closure of Trading Window

    This is to inform you that as per the Company''s Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of the Company will be closed with effect from Wednesday, 1st April, 2020 till 48 (forty-eight) hours after the declaration of the Audited Financial Results of the Company for the Quarter and Financial Year ending 31st March, 2020.

  • Mar 31, 2020 15:21 Source: NSE

    Astec LifeSciences Limited

    Astec LifeSciences Limited has informed the Exchange regarding Board meeting held on March 31, 2020.

  • Mar 31, 2020 15:04 Source: BSE

    Astec Lifesciences - Re-Appointment Of Mr. Ashok V. Hiremath As The 'Managing Director'

    This is to inform you that the Board of Directors of Astec LifeSciences Limited ('the Company'), at its Meeting held today, i.e., on Tuesday, 31st March, 2020 (which commenced at 1.30 p.m. by means of Video Conferencing and concluded at 2.45 p.m.), has, based on the recommendation of the Nomination and Remuneration Committee of the Board of Directors of the Company, re-appointed Mr. Ashok V. Hiremath as the 'Managing Director' of the Company for a further period of 2 (two) years commencing from 1st April, 2020 upto 31st March, 2022. The re-appointment of Mr. Ashok V. Hiremath as the 'Managing Director' of the Company is subject to approval of the Shareholders at the next General Meeting of the Company and such other approval(s), as may be required.

  • Mar 23, 2020 20:50 Source: BSE

    Astec Lifesciences - Intimation / Disclosure Of Event Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

    This is to inform that, due to the global outbreak of Coronavirus disease 2019 (COVID-19) pandemic, the Company has been taking a series of measures to ensure safety and health of all its employees and to ensure compliance with various directives being issued by Central/State/Municipal authorities. In view of the lockdown in many of the States across the country, the operations at many of our locations are disrupted. The operations in all our manufacturing facilities and most of the sales locations have either been scaled down or will be shut down depending upon the situation. Also, all the employees in our Head Offices have been instructed to work from home. In this evolving situation, the overall adverse impact on the operations of the Company is not immediately assessable. The duration of this shutdown will depend upon directives to be further issued by the respective Government authorities in this regard.

  • Jan 30, 2020 18:21 Source: BSE

    Astec Lifesciences - Amendment To The 'Policy On Materiality Of Related Party Transactions And On Dealing With Related Party Transactions' Of The Company

    The Board of Directors has amended the ''Policy on Materiality of Related Party Transactions and on Dealing with Related Party Transactions'' of the Company in order to align the same with the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Companies Act, 2013 and the Rules framed thereunder (as amended from time to time).

  • Jan 30, 2020 18:17 Source: BSE

    Astec Lifesciences - Re-Constitution Of The Committees Of The Board Of Directors

    Consequent to resignation of Mr. Sitendu Sharma as an ''Independent Director'' of the Company and appointment of Mr. Rishinaradamangalam Ramakrishna Govindan as an ''Additional Director (Non-Executive, Independent Director)'' of the Company, the following Committees of the Board of Directors of the Company have been re-constituted: i) Audit Committee ii) Stakeholders'' Relationship Committee iii) Risk Management Committee iv) Compensation Committee.

  • Jan 30, 2020 18:13 Source: BSE

    Astec Lifesciences - Induction Of Mr. Rishinaradamangalam Ramakrishna Govindan As An 'Additional Director (Non - Executive, Independent Director)' On The Board

    The Board of Directors of the Company, based on the recommendation of the Nomination and Remuneration Committee of the Board of Directors, has appointed Mr. Rishinaradamangalam Ramakrishna Govindan [Director Identification Number (DIN): 02148801] as an ''Additional Director'' (Non-Executive, Independent Director) for a period of 5 (five) years with effect from 30th January, 2020 upto 29th January, 2025, subject to approval of the Shareholders of the Company.

  • Jan 30, 2020 18:09 Source: BSE

    Astec Lifesciences - Announcement under Regulation 30 (LODR)-Change in Directorate

    The Board took note of the resignation tendered by Mr. Sitendu Sharma, Director (Non-Executive, Independent Director) who has stepped down from the position of ''Independent Director'' of the Company with effect from the close of business hours today, i.e., 30th January, 2020. Further,the Board of Directors of the Company, based on the recommendation of the Nomination and Remuneration Committee of the Board of Directors, has appointed Mr. Rishinaradamangalam Ramakrishna Govindan [Director Identification Number (DIN): 02148801] as an ''Additional Director'' (Non-Executive, Independent Director) for a period of 5 (five) years with effect from 30th January, 2020 upto 29th January, 2025, subject to approval of the Shareholders of the Company.

  • Jan 30, 2020 18:02 Source: BSE

    Astec Lifesciences - Announcement under Regulation 30 (LODR)-Cessation

    The Board took note of the resignation tendered by Mr. Sitendu Sharma, Director (Non-Executive, Independent Director) who has stepped down from the position of ''Independent Director'' of the Company with effect from the close of business hours today, i.e., 30th January, 2020.

  • Jan 30, 2020 18:02 Source: BSE

    Astec Lifesciences - Announcement under Regulation 30 (LODR)-Resignation of Director

    The Board took note of the resignation tendered by Mr. Sitendu Sharma, Director (Non-Executive, Independent Director) who has stepped down from the position of ''Independent Director'' of the Company with effect from the close of business hours today, i.e., 30th January, 2020.

BOARD MEETING

Meeting Date : Jan 30, 2020
Remark : Quarterly Results